Shijiazhuang No.4 Pharmaceutical Group (02005.HK): Peritoneal Dialysis Solution (Bicarbonate-G1.5%) (2000ml) Obtains Drug Production Registration Approval

Zhitong Finance APP news, SSY Group (02005.HK) announced that the Group has obtained the drug production registration approval from China's National Medical Products Administration for peritoneal dialysis solution (bicarbonate-G1.5%) (2000ml), which belongs to Class 3 chemical drugs and is deemed to have passed the consistency evaluation. It is mainly used for peritoneal dialysis in patients with chronic renal failure, and is used when hypermagnesemia has not been sufficiently improved.